Functional impact of dendritic cell phenotype in a mouse model of myositis
Functional impact of dendritic cell phenotype in a mouse model of myositis
批准号:
7799180
负责人:
DANA P ASCHERMAN
金额:
$6.69万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-03 至 2010-08-31
关键词:
AddressAdjuvantAdoptive TransferAntibody FormationAntigen TargetingAntigensAutoantibodiesAutoimmune DiseasesAutoimmune ResponsesAutoimmunityBlocking AntibodiesBypassBystander SuppressionCardiomyopathiesCell Culture TechniquesCell physiologyCellsCharacteristicsChemicalsClinical TrialsComplementCongenic MiceCongenic StrainConnective Tissue DiseasesCoupledDendritic CellsDevelopmentDiseaseDisease modelEncephalomyelitisExperimental Autoimmune EncephalomyelitisFutureHistidine-tRNA LigaseHumanIdiopathic Inflammatory MyopathiesImmune System DiseasesImmune TargetingImmune responseImmunizationImmunologicsImmunosuppressionIn VitroInflammationInflammatoryInsulin-Dependent Diabetes MellitusJo-1 antibodyLabelLigaseLinkLungLung InflammationLymphocyteMaintenanceMeasurementMediatingMethodsModelingMusMuscleMyosin ATPaseMyositisOrganPathogenesisPhenotypePhysiologic pulsePopulationPreparationPrimary biliary cirrhosisProcessProductionPublishingPulmonary FibrosisPyruvate Dehydrogenase ComplexRegimenRegulatory T-LymphocyteRelative (related person)RelianceRoleSpleenStaining methodStainsStimulusStructure of parenchyma of lungSyndromeSystemT cell responseT-Cell ProliferationT-LymphocyteTherapeuticTissuesVariantWorkanergyantigen challengebaseclinically significantcomparativeconditioningcytokinehuman diseaseimmunoregulationin vivoinsightlymph nodesmouse modelpreventpublic health relevanceresearch studyresponsetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In the idiopathic inflammatory myopathies, disease pathogenesis remains largely undefined. However, we have recently published work demonstrating that immunization of different NOD and C57BL/6 congenic strains with murine histidyl-tRNA synthetase (Jo-1) generates muscle and lung inflammation resembling features of the anti-synthetase syndrome. The experimental approach outlined in this application extends these earlier studies through functional manipulation of dendritic cell (DC) phenotype to define characteristics of the Jo-1-specific immune response contributing to disease expression. Specific Aim 1 employs different in vitro cytokine preparations and maturation stimuli to generate Jo-1-loaded DCs capable of skewing toward Th1, Th2, or Th17 immune responses targeting this antigen. Subsequent immunization of NOD and C57BL/6 congenic mice with Jo- 1-pulsed DCs cultivated under defined conditions will highlight the impact of antigen-specific T cell polarization on tissue inflammation in comparison to Jo-1/CFA immunization. Adoptive transfer of organ-infiltrating lymphocytes from DC-immunized to naive mice will firmly establish the relationship between Jo-1-specific autoimmune responses and the anti-synthetase syndrome. Parallel measurement of CFSE-labeled T cell proliferative responses and intracellular cytokine staining of antigen-challenged lymphocytes derived from spleen and organ-draining lymph nodes of DC-immunized mice will further link the observed tissue phenotype to Th17 and/or Th1-polarized, Jo-1-specific T cell responses. In contrast, use of alternative cytokine conditioning in Specific Aim 2 will generate Jo-1-loaded "tolerogenic" DCs capable of blocking disease induction and, more importantly, re-establishing tolerance in existing disease. Complementing the in vivo assessment of Jo-1-pulsed tolerogenic DC immunization in disease preventioNot applicable.melioration, in vitro transwell mixing and antibody blocking experiments will define the relative contribution of anergy, bystander suppression, and contact-mediated inhibition to antigen-specific regulatory T cell function. The mechanistic insight provided by these studies will help to define immunologic targets and therapeutic approaches applicable to future human clinical trials. PUBLIC HEALTH RELEVANCE: This project employs functional manipulation of antigen-pulsed dendritic cells to define the role of Jo-1-specific T cells in a murine model of inflammatory myopathy. This approach will clarify mechanisms of disease initiation/perpetuation and establish the feasibility of antigen- specific, dendritic cell-mediated tolerance induction. The latter objective is relevant to the treatment of multiple autoimmune diseases for which global immunosuppression is the only therapeutic option.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease
-
批准号:10532784
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2021
-
负责人:DANA P ASCHERMAN
-
依托单位:
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease
-
批准号:10362978
-
项目类别:
-
资助金额:$20.8万
-
财政年份:2021
-
负责人:DANA P ASCHERMAN
-
依托单位:
Innate Immune Activation in Autoimmune Myopathy
-
批准号:9926715
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2017
-
负责人:DANA P ASCHERMAN
-
依托单位:
Innate Immune Activation in Autoimmune Myopathy
-
批准号:9286500
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2017
-
负责人:DANA P ASCHERMAN
-
依托单位:
Peripheral Blood Biomarkers of RA-associated Interstitial Lung Disease
-
批准号:8278446
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:DANA P ASCHERMAN
-
依托单位:
Peripheral Blood Biomarkers of RA-associated Interstitial Lung Disease
-
批准号:8397571
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:DANA P ASCHERMAN
-
依托单位:
Peripheral Blood Biomarkers of RA-associated Interstitial Lung Disease
-
批准号:8142414
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:DANA P ASCHERMAN
-
依托单位:
Peripheral Blood Biomarkers of RA-associated Interstitial Lung Disease
-
批准号:8696779
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:DANA P ASCHERMAN
-
依托单位:
Functional impact of dendritic cell phenotype in a mouse model of myositis
-
批准号:7659076
-
项目类别:
-
资助金额:$20.45万
-
财政年份:2009
-
负责人:DANA P ASCHERMAN
-
依托单位:
Functional impact of dendritic cell phenotype in a mouse model of myositis
-
批准号:8188933
-
项目类别:
-
资助金额:$10.23万
-
财政年份:2009
-
负责人:DANA P ASCHERMAN
-
依托单位:
Jo-1-specific T Cell Responses in Polymyositis
-
批准号:7238700
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2003
-
负责人:DANA P ASCHERMAN
-
依托单位:
Jo-1-specific T Cell Responses in Polymyositis
-
批准号:6908278
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2003
-
负责人:DANA P ASCHERMAN
-
依托单位:
Jo-1-specific T Cell Responses in Polymyositis
-
批准号:6758502
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2003
-
负责人:DANA P ASCHERMAN
-
依托单位:
Jo-1-specific T Cell Responses in Polymyositis
-
批准号:6613238
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:DANA P ASCHERMAN
-
依托单位:
Jo-1-specific T Cell Responses in Polymyositis
-
批准号:7097976
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2003
-
负责人:DANA P ASCHERMAN
-
依托单位:
海外基金